Synthetic liver X receptor agonist T0901317 attenuates high glucose-induced oxidative stress, mitochondrial damage and apoptosis in cardiomyocytes
Authors:
- 1 January 2014
- journal article
- Published by Elsevier in Acta Histochemica
- Vol. 116 (1) , 214-221
Abstract
No abstract availableKeywords
Funding Information
- Foundation for University Youth Academic Backbone of Heilongjiang Province (1253G062)
- Open Foundation for Child Nerve Rehabilitation Laboratory of Jiamusi University
This publication has 36 references indexed in Scilit:
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXRNature Reviews Molecular Cell Biology, 2012
- Diabetic cardiomyopathy: mechanisms and therapeutic targetsDrug Discovery Today: Disease Mechanisms, 2010
- Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS–NF-κB pathwayBiochemical and Biophysical Research Communications, 2007
- Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic GluconeogenesisJournal of Biological Chemistry, 2003
- Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuliJournal of Cell Biology, 2002
- Hyperglycemia-Induced Apoptosis in Mouse MyocardiumDiabetes, 2002
- Nuclear Receptors and Lipid Physiology: Opening the X-FilesScience, 2001
- Mitochondria as the central control point of apoptosisTrends in Cell Biology, 2000
- Weak antioxidant defenses make the heart a target for damage in copper-deficient ratsFree Radical Biology and Medicine, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994